Widespread inaction on hearing loss revealed in new poll of U.S. adults … Small pharmacies cheer Texas’ passage of PBM middleman reform law … Employers can require COVID vaccine under new EEOC guidance...
Clinical Briefs for Friday, October 11
By
Alicia Lasek
Oct 10, 2019
Research sheds new light on how brain forms, recalls memories … FDA approves Dexcom G6 Pro continuous glucose monitor … Acute respiratory viral illness surveillance possible in long-term care: study...
Six states join coronavirus test-purchasing compact; VA tries statewide COVID app
By
Alicia Lasek
Aug 06, 2020
The governors of six states, including Republicans and Democrats, have formed an interstate compact to negotiate the purchase of 3 million COVID-19 antigen tests.
Clinical briefs for Tuesday, April 27
By
Alicia Lasek
Apr 27, 2021
Frailty and cognitive impairment not reasons to withhold anticoagulation in atrial fibrillation, docs say … Parkinson’s patients’ treatment goals reflect disease progression … Study looks at how...
Clinical briefs for Friday, Aug. 27
By
Alicia Lasek
Aug 27, 2021
Big name audio companies fill in while hearing aid reform lags: report … Second J&J shot ‘significantly’ increases COVID-19 antibodies, says firm, which heads toward approval process … AHCA releases...
Clinical briefs for Friday, Jan. 13
By
Alicia Lasek
Jan 13, 2023
COVID-19 pneumonia requires longer ventilation, but outcomes similar to other pneumonias … Six daily minutes of intense exercise vs. fasting could delay dementia onset: study … Protein may be biomarker...
Active lifestyle may slow inherited frontotemporal dementia
By
Alicia Lasek
Jan 08, 2020
A lifestyle that’s physically and mentally active may help slow the progression of inherited frontotemporal dementia, according to an ongoing study.
Clinical briefs for Monday, Oct. 5
By
Alicia Lasek
Oct 05, 2020
Blood pressure meds reduce mortality in flu and pneumonia, study finds … Purpose in life linked to fewer dementia-related problems … Poor cognitive performance predicts impaired activities of daily...
Alzheimer’s drug slows mental, functional decline in Eli Lilly trial
By
Alicia Lasek
Jan 12, 2021
Participants who took donanemab for 76 weeks showed 32% slower decline in thinking and daily function compared with those in a placebo group.
Clinical briefs for Friday, Sept. 18
By
Alicia Lasek
Sep 18, 2020
Nursing home commission makes 27 recommendations, calls for ‘greater leadership role’ from CMS … Heparin nasal spray to be tested as COVID prevention … One in 10 older dental patients prescribed...